Back to company

FORWARD PHARMA A/S: Financial statements 2018

CVR: 28865880

FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 0 and a net result of DKK -54,294,876 compared with DKK 880,210,000 the year before. Equity amounted to DKK 534,575,582. The solvency ratio was 99%. The company had 3 employees in the financial year.

Revenue
0 kr.
Gross Profit
-7,608,927 kr.
Profit/Loss
-54,294,876 kr.
Equity
534,575,582 kr.
Total Assets
539,859,395 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20180-7.6 mio.-54.3 mio.534.6 mio.3
20171.3 mia.-880.2 mio.89.4 mio.-
2016--2 mio.189.7 mio.-
2015---51.1 mio.176.7 mio.-
2014---13.7 mio.238 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on FORWARD PHARMA A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2018

FORWARD PHARMA A/S: The 2017 annual report is outMay 31, 2018

FORWARD PHARMA A/S has published its annual report for 2017. Revenue came to DKK 1,250,000,000, and the net result was DKK 880,210,000.

About FORWARD PHARMA A/S

FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005 and dissolved in 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees. In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity amounted to DKK 488,330,233.